|1.||Pertinhez, Thelma A: 1 article (09/2015)|
|2.||Santos, Robson A S: 1 article (09/2015)|
|3.||Moreau, Thierry: 1 article (09/2015)|
|4.||Calixto, Joao B: 1 article (09/2015)|
|5.||Blaber, Michael: 1 article (09/2015)|
|6.||Juliano, Luiz: 1 article (09/2015)|
|7.||Assis, Diego M: 1 article (09/2015)|
|8.||Gauthier, Francis: 1 article (09/2015)|
|9.||Juliano, Maria A: 1 article (09/2015)|
|10.||Kouyoumdjian, Maria: 1 article (09/2015)|
|1.||Chronic Obstructive Pulmonary Disease (COPD)
01/01/2013 - "Comparing the responses to a T-tube trial and PS-6, the patients with old age, poor pulmonary compliance (≤40 ml/cmH2O) and chronic obstructive pulmonary disease had a higher heart rate (difference [95% CI]: 4 [0,8], 5 [2,9], 5 [0,10] beats/minute, respectively) and systolic blood pressure (10 [4,16], 11 [5,16], 7 [0,13] mmHg, respectively) after the T-tube trial. "
10/01/1993 - "These data demonstrate that PS-6 blend UG vapor promotes preneoplastic lesions and induces CYP2B in female mouse liver under exposure conditions in which it causes liver tumors, and suggest that a more recent blend of UG may have similar effects."
06/01/1996 - "Given that these effects are potentially related to tumor promotion and the general lack of genotoxic activity, MTBE and 91-01 UG may exhibit tumor promoting activity similar to that seen with PS-6 UG. "
06/01/1996 - "PS-6 UG is a liver tumor promoter in N-nitrosodiethylamine-initiated female mice and produces short-term effects potentially relevant to its tumor promoting ability. "
10/01/1993 - "of PS-6 blend UG, the same gasoline blend used in the cancer bioassay. "
06/01/1996 - "PS-6 unleaded gasoline (UG) and methyl tert-butyl ether (MTBE), an UG additive, with long-term exposure at high concentrations increased liver tumors selectively in female mice. "
|3.||Congenital Cystic Adenomatoid Malformation of Lung (Cystic Adenomatoid Malformation of Lung)
04/01/2009 - "The distribution of diagnoses was as follows: bronchogenic cyst(s) (BC) - 5 patients; pulmonary sequestration (PS) - 6 patients; congenital lobar emphysema (CLE) - 4 patients; congenital cystic adenomatoid malformation (CCAM) Type I - 3 patients, and PS and CCAM coexistence - 1 patient. "
|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
|1.||cyclo(Arg-Pro) (CI 4)
|2.||Gasoline (Diesel Fuel)
|3.||Bradykinin Receptors (Bradykinin Receptor)
|4.||Ouabain (G Strophanthin)
|6.||Congenital lobar emphysema
|7.||methyl tert-butyl ether (MTBE)
|8.||PS 5 (PS-5)